Venture Life Group (LON:VLG) Stock Passes Above 50 Day Moving Average – Here’s What Happened

Shares of Venture Life Group plc (LON:VLG) passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 60.91 and traded as high as GBX 68. Venture Life Group shares last traded at GBX 66, with a volume of 763,578 shares.

Venture Life Group Trading Up 0.3%

The company has a current ratio of 4.71, a quick ratio of 1.48 and a debt-to-equity ratio of 0.82. The company has a market capitalization of £81.87 million, a price-to-earnings ratio of 15.38, a PEG ratio of 5.67 and a beta of 0.23. The company has a fifty day moving average of GBX 60.96 and a 200-day moving average of GBX 64.42.

Venture Life Group (LON:VLG) last announced its earnings results on Tuesday, March 31st. The company reported GBX (1.49) earnings per share (EPS) for the quarter. Venture Life Group had a return on equity of 7.82% and a net margin of 17.42%.The business had revenue of GBX 3,517 million for the quarter. As a group, equities research analysts anticipate that Venture Life Group plc will post 6.1391542 earnings per share for the current fiscal year.

Insider Transactions at Venture Life Group

In other Venture Life Group news, insider Paul McGreevy bought 15,663 shares of the stock in a transaction on Wednesday, June 3rd. The shares were bought at an average price of GBX 64 per share, with a total value of £10,024.32. Over the last 90 days, insiders have acquired 80,207 shares of company stock worth $5,004,160. Insiders own 7.27% of the company’s stock.

Venture Life Group Company Profile

Venture Life is an international consumer self-care company focused on developing and commercialising products for the global self-care market helping our consumers live a longer healthier and more rewarding life.

Headquartered in the UK, the Group’s product portfolio includes Balance Activ in the area of women’s intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally.